Planned sale

Kura Oncology (KURA): Officer filed to sell ~$71K

POWL BRIAN T, Officer at Kura Oncology, filed to sell ~$71K of Kura Oncology shares.

~$71K
planned to sell · 9,196 shares, around Nov 16, 2026
Planned for
Nov 16, 2026
Notice filed
Nov 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 24, 2026InsiderOfficer sold ~$225K of KURA shares in the open market
  2. Sep 28, 2026Insider · 5 peopleInsiders: 6 sales (~$519K)
  3. Sep 29, 2026Insider · 3 peopleInsiders: 3 sales (~$515K)
  4. Oct 27, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 8.9%
  5. Nov 10, 2026Company filing · Form 8-K · ResultsReported its results
  6. Nov 13, 2026Insider · First insider buy since Sep 2025CEO purchased ~$754K of KURA shares in the open market
  7. Nov 16, 20265% stakeBVF PARTNERS L P/IL reported a passive stake (13G) of 7.5%
  8. Nov 16, 2026InsiderCEO purchased ~$750K of KURA shares in the open market
View the official recordSEC Form 144

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Kura Oncology

For Kura Oncology, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KURA page.

How this filing works

Explore the data

Common questions

Which Kura Oncology (KURA) insider traded, and how much?

POWL BRIAN T, Officer at Kura Oncology, filed to sell ~$71K of Kura Oncology shares. 9,196 shares, Form 144 notice of a planned sale.

When did it happen, and when was it made public?

Planned for: Nov 16, 2026. Notice filed: Nov 16, 2026.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Kura Oncology recently?

For Kura Oncology, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the KURA page.

Does this mean KURA stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Kura Oncology

Everything OQRO holds on this company is on its KURA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data